Posted on 10/31/2006 7:56:57 PM PST by Coleus
NEW ROCHELLE, N.Y.--(BUSINESS WIRE)--The tremendous progress made in identifying, understanding, and working with adult stem cells to harness their regenerative potential and grow functional human tissues in the laboratory is presented in a comprehensive review of the promise and challenges of engineering living tissues, published online ahead of print in the November 2006 issue (Volume 12, Number 11) of Tissue Engineering, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com) The paper is available free online at www.liebertpub.com/ten.
In a report entitled, “Ex Vivo Engineering of Living Tissues with Adult Stem Cells,” Bonnie Barrilleaux, B.S., Donald G. Phinney, Ph.D., Darwin J. Prockop, M.D., Ph.D. and Kim O’Connor, Ph.D., from Tulane University (New Orleans, LA) and Tulane’s Health Science Center describe the revolutionary advances achieved in identifying the optimal adult stem cell sources for generating tissue substitutes and refining the complex processes required to grow these cells ex vivo and induce them to replicate and differentiate into specific tissue types.
“The identification of optimal roles for different types of stem cells is critical at this time of rapid scientific discovery,” says Peter C. Johnson, M.D., President and CEO of Scintellix, LLC and Co-Editor-in-Chief of Tissue Engineering.
The authors of the report outline future directions for adult stem cell research that will accelerate progress in developing replacement tissues for the nascent field of regenerative medicine. They emphasize the need to understand more clearly the basic biology of stem cells and the importance of advances in engineering sciences that will contribute to the development of better natural and synthetic scaffold materials and innovative scaffold designs that will exploit emerging micro- and nanoscale technologies.
Another promising area of research focuses on the use of allogeneic stem cell sources for tissue engineering when a patient’s own stem cells are not available.
Tissue Engineering is an authoritative peer-reviewed journal published monthly in print and online that brings together scientific and medical experts in the fields of biomedical engineering, materials science, molecular and cellular biology, and genetic engineering. Tissue Engineering is the official journal of the Tissue Engineering & Regenerative Medicine International Society (TERMIS). Tables of contents and a free sample issue may be viewed online at www.liebertpub.com/ten.
Mary Ann Liebert, Inc., is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Human Gene Therapy, Stem Cells and Development, and Cloning and Stem Cells. Its biotechnology trade magazine, Genetic Engineering News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 60 journals, books, and newsmagazines is available at www.liebertpub.com.
The FDA has to be quicker at approving these treatments, so we can start saving/improving lives.
BTTT!
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.